HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER

Clinical trials for HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER trials appear

Sign up with your email to follow new studies for HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Massive 14,000-Patient review aims to map China's breast cancer care

Knowledge-focused Not yet recruiting

This study aims to understand how advanced breast cancer is actually treated in China by analyzing the medical records of 14,000 patients. It will look at which drugs are used first, how long treatments last, and what side effects patients experience. The goal is to gather real-w…

Matched conditions: HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER

Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:28 UTC

HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER

Get alerted when new HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER trials appear

Massive 14,000-Patient review aims to map China's breast cancer care